This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Marvell's a Winter Flop, Summer Flip

Editor's note: Jim Cramer told viewers of his "Mad Money" TV show on Tuesday that Intuitive Surgical (ISRG) and Potash (POT) are two ugly ducklings set to become beautiful swans. Here's another stock with those same characteristics.

NEW YORK ( TheStreet) -- At the beginning of the year, chip giant Marvell (MRVL - Get Report), which had dropped by more than 50% in 2012, was on my short list of ugly duckling companies that I felt could turn into swans. Not only did I sense that Marvell had been punished enough, but I felt -- with a little stroke of luck -- the stock could post unsuspecting gains.

Winter Flop, Summer Flip
MRVL Chart MRVL data by YCharts

I figured, how much worse could things get? Since the clock struck midnight into 2013, this strategy has worked to perfection. Not only have shares of Marvell been up by as much as 63% on the year, but since the stock bottomed at $6.98 in December, Marvell is up closer to 70%. Now, investors are wondering how much better can things get?

That's the right question to ask, because this company is anything but a flawless operation.

I'm not suggesting that Marvell's direction is all downhill from here. But I do worry that investors who are risking additional gains from this level may get burned. Worse, they may end up roasting themselves.

Marvell's situation has many layers. Not only has the company been plagued by litigation, including having to pay $1.17 billion to Carnegie Mellon in a patent suit, but it has also been left behind by the likes of Qualcomm (QCOM) and Broadcom (BRCM), which have chipped away at Marvell's strength in areas like mobile and wireless.

To complicate matters, in Marvell's core storage market, although the company is doing well, rivals such as LSI (LSI) are ramping up products to stunt Marvell's turnaround potential. And I haven't even mentioned the uphill battle Marvell faces in areas like network processing, where (among others) Cisco (CSCO) is a force.

While these commercial clashes are going on, management still has to hold the pieces together in court battles. In that regard, it's remarkable that the company nevertheless managed to post decent results in its fiscal first quarter -- relatively speaking. Although revenue declined 8% year-over-year, it still managed to beat Street estimates by almost 2%. But it wasn't all good news.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
INTC $32.47 0.00%
MRVL $15.01 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs